Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
Номер патента: EP1471884A1
Опубликовано: 03-11-2004
Автор(ы): Amyn GlaxoSmithKline Inc. SAYANI, Bettina GlaxoSmithKline Inc. FONG, Elita Y. GlaxoSmithKline Inc. HO, Ian GlaxoSmithKline Inc. BUXTON, Keith Glaxosmithkline Biggadike, Kenton Lewis GlaxoSmithKline Inc. REED, Peter Terence GlaxoSmithKline DALEY-YATES
Принадлежит: Glaxo Group Ltd
Опубликовано: 03-11-2004
Автор(ы): Amyn GlaxoSmithKline Inc. SAYANI, Bettina GlaxoSmithKline Inc. FONG, Elita Y. GlaxoSmithKline Inc. HO, Ian GlaxoSmithKline Inc. BUXTON, Keith Glaxosmithkline Biggadike, Kenton Lewis GlaxoSmithKline Inc. REED, Peter Terence GlaxoSmithKline DALEY-YATES
Принадлежит: Glaxo Group Ltd
Реферат: There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein: (a) a glucocorticoid of formula (I), wherein R represents ethyl or a 5 membered heterocyclic aromatic ring containing 1 to 3 heteroatoms selected from O, N and S, optionally substituted by one or more methyl or halogen atoms or a solvate thereof, as a medicament; and (b) a solubilising agent for assisting the solubilisation of the medicament in the aqueous carrier liquid.
Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
Номер патента: US20050209206A1. Автор: Keith Biggadike,Ian Buxton,Kenton Reed,Amyn Sayani,Peter Daley-Yates,Bettina Fong,Elita Ho. Владелец: Glaxo Group Ltd. Дата публикации: 2005-09-22.